Producción científica
Buscar por:
Lista
| Publicación |
|
P.J. García, A. Sola Leyva, Y.M. Jabalera Ruz, T. Pozo Gualda, P.M. Luque Navarro, L.C. Lopez Cara, C. Jiménez Lopez, G.R. Iglesias Salto
and
M.P. Carrasco Jimenez,
"QUIMIOTERAPIA DIRIGIDA Y FOTOTERMIA COMBINADAS BASADA EN EL USO DE NANOPARTÍCULAS MAGNÉTICAS BIOMIMÉTICAS FUNCIONALIZADAS CON UN NUEVO INHIBIDOR DE CHOKOL, PL48", "II CONGRESO INVESTIGACION PTS", None-None, 2022
|
|
S. Salido, A. Alejo-Armijo, C. Cuadrado, J. Altarejos-Caballero, M.X. Fernandes, E. Salido-Ruiz
and
M. Díaz Gavilán,
"Synthesis and evaluation of molecules with a 2,8-dioxabicyclo[3.3.1]nonane scaffold as human lactate dehydrogenase a (hLDHA) inhibitors", "XIV International Hyperoxaluria Conference", None-None, 2022
|
|
G. Venkatesh, Y. Sixto López, P. Vennila, Y. Sheena Mary, J. Correa-Basurto, Y. Shyma Mary
and
A. Manikandan,
"An investigation on the molecular structure, interaction with metal clusters, anti-Covid-19 ability of 2-deoxy-D-glucose: DFT calculations, MD and docking simulations", Journal of Molecular Structure, vol.1258
, -, 2022
|
|
P. Garcia -Molina, A. Sola Leyva, P.M. Luque Navarro, A. Laso, P. Ríos-Marco, A. Ríos Guadix, D. Lanari, A. Torretta, E. Parisini, L.C. Lopez Cara, C. Marco De La Calle
and
M.P. Carrasco Jimenez,
"Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines", Pharmaceutics, vol.14
, 426-, 2022
|
|
F. Arias Bordajandi, F. Franco Montalbán, M. Romero Pérez, J.M. Duarte Pérez, M.D. Carrión Peregrina
and
M.E. Camacho-Quesada,
"Bioactive imidamide-based compounds targeted against nitric oxide synthase", Bioorganic Chemistry, vol.120
, -, 2022
|
|
P.M. Luque Navarro, E. Mariotto, M. Ballarotto, G. Rubbini, F.J. Aguilar-Troyano, A. Fasiolo, A. Torretta, E. Parisini, A. Macchiarulo , A. Laso, C. Marco De La Calle, G. Viola, M.P. Carrasco Jimenez
and
L.C. Lopez Cara,
"Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors", Pharmaceutics, vol.14
, 715-, 2022
|
|
I. Balbuena-Rebolledo, A.M. Rivera-Antonio, Y. Sixto López, J. Correa-Basurto, M.C. Rosales-Hernández, J.E. Mendieta-Wejebe, F.J. Martínez-Martínez, I.M. Olivares-Corichi, J.R. García-Sánchez, J.A. Guevara-Salazar, M. Bello
and
I.I. Padilla-Martínez,
"Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6", Pharmaceuticals, vol.15
, 1-23, 2022
|
|
V. Corpas-López, V. Díaz Sáez, F. Morillas Márquez, F. Franco Montalbán, M. Díaz Gavilán, M. Lopez-Viota Gallardo, J.A. Gómez Vidal
and
J. Martín Sánchez,
"Effectiveness of an O-Alkyl hydroxamate in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial", Animals, vol.12
, 2700-, 2022
|
|
|
Última actualización del SICA: 30/04/2025
julio 2025
ANTERIOR